Cardiovascular implications of long-term AAS use - what the actual data says

Want to lay out the actual cardiovascular data on long-term AAS use because I see too much fear-mongering alongside too much dismissal and neither is useful. The honest picture: left ventricular hypertrophy is real and dose-dependent. HDL suppression is consistent across all studies. Hematocrit elevation with EQ and high-dose test is well documented. The key question is reversibility. LVH shows meaningful regression in 6-12 months off cycle in most studies. Lipids recover in 3-6 months. Hematocrit normalises fastest, usually weeks. Long-term risk is cumulative and dose-dependent. Running less for longer is better for the heart than high doses for short periods.

Good post. The LVH reversibility data is what I always point to when this comes up. The doom posts ignore the fact that many cardiac changes are reversible with time off. Not all of them, cumulative exposure matters, but for someone blasting sensibly with cruise periods the picture is less bleak than some people paint it.

This is the kind of post this forum needs more of. Real data, honest assessment, no agenda either way. The reversibility point is what most people overlook in both directions. Do you have any data on whether guys who cruise long term rather than fully coming off see comparable LVH regression?

Thank you for this. I have been looking for something to share with a training partner who is starting AAS next year. The fear-mongering makes people avoid information rather than make informed choices. Having the evidence laid out clearly is more useful than either extreme.

The cumulative and dose-dependent part is the key message that too many people miss. Your cardiovascular health at year 1 of sensible blasting is very different from year 10 of high-dose year-round use. Blanket statements about gear and heart health apply to very different usage patterns than what most of us here are actually doing.